Categories AlphaGraphs, Earnings, Health Care

HEXO Corp (HEXO) disappoints in Q3

Late on Wednesday, HEXO Corp (TSX: HEXO; NYSE-A: HEXO) reported a basic net loss per share that widened to CAD 0.04 in the third quarter of 2019, from CAD 0.01 per share a year ago, weighed down by higher operating expenses and taxes.   

HEXO ended its extended trading down 0.78% on Wednesday.

Total net sales jumped to CAD 13 million (~$9.75 million), from just about CAD 1.2 million in the same quarter last year, helped by increased adult use sales. Analysts were expecting revenues of $10.96 million.

hexo vs aurora updated

In the third quarter, adult-use sales accounted for 91% of total revenue. Meanwhile, in the medical segment, net revenues declined 7% to CAD 1.09 million, due to overall weakness in medical sales.

CEO Sebastien St-Louis said, “This quarter saw HEXO remain on-track as it continues ramping up to $400 million in revenue in fiscal 2020, including completing the first harvest in our 1 million sq. ft. Expansion and preparing to fund our ongoing expansion projects and innovation initiatives by entering a $65 million syndicated credit facility.”

The Canadian cannabis company said it produced 9,804 kg of dried cannabis, an increase of 98% over the previous quarter. It also completed first harvests in new 1,000,000 sq. ft. expansion as it continues ramping up to annual production capacity of 150,000 kg of dried cannabis.

Also Read: The question every pot investor asks himself – Aurora Cannabis or Hexo?

The company completed the acquisition of Newstrike Brands in May. Earlier in March, HEXO entered into an agreement to acquire Newstrike for CAD$263 million. Following this acquisition, HEXO estimates fiscal 2020 net and gross revenues from the sale of cannabis in Canada to be over CAD$400 million and CAD$479 million, respectively.

Last month, HEXO formalized its US presence by appointing Michael Monahan as CFO and establishing HEXO USA Inc. in Delaware. The company also named Donald Courtney as its Chief Operating Officer in May. With the passing of the Farm Bill to allow CBD extraction from hemp, HEXO Corp is confident of seizing a significant portion of market share in the US.

HEXO’s shares have advanced 23% from January 23, 2019, the date which the company started trading on the NYSE American. HEXO stock closed down 2.86% at $6.45 today.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top